Shots:

• AstraZeneca enters into an agreement with Schrödinger to deploy Schrödinger’s advanced computing platform for accelerating its drug discovery efforts
• AstraZeneca will utilize predictive physics-based modeling and machine learning platform to identify new therapies including an improvement in the design of its compounds 
• Schrödinger’s platform predicts the potency of a molecule binding to a target protein and optimizes its chemical properties and reduces the number of compounds to be synthesized before settling on a lead candidate

Click here to­ read full press release/ article

Ref: Schrödinger | Image: AstraZeneca